fbpx
Wikipedia

Ground-glass opacity

January 18, 2023

Ground-glass opacity (GGO) is a finding seen on chest x-ray (radiograph) or computed tomography (CT) imaging of the lungs. It is typically defined as an area of hazy opacification (x-ray) or increased attenuation (CT) due to air displacement by fluid, airway collapse, fibrosis, or a neoplastic process.[1] When a substance other than air fills an area of the lung it increases that area's density. On both x-ray and CT, this appears more grey or hazy as opposed to the normally dark-appearing lungs. Although it can sometimes be seen in normal lungs, common pathologic causes include infections, interstitial lung disease, and pulmonary edema.[2][3]

High-resolution CT image showing ground-glass opacities in the periphery of both lungs in a patient with COVID-19 (red arrows). The adjacent normal lung tissue with lower attenuation appears as darker areas.

Definition

In both CT and chest radiographs, normal lungs appear dark due to the relative lower density of air compared to the surrounding tissues. When air is replaced by another substance (e.g. fluid or fibrosis), the density of the area increases, causing the tissue to appear lighter or more grey.[4]

Ground-glass opacity is most often used to describe findings in high-resolution CT imaging of the thorax, although it is also used when describing chest radiographs. In CT, the term refers to one or multiple areas of increased attenuation (density) without concealment of the pulmonary vasculature. This appears more grey, as opposed to the normally dark-appearing (air-filled) lung on CT imaging. In chest radiographs, the term refers to one or multiple areas in which the normally darker-appearing (air-filled) lung appears more opaque, hazy, or cloudy. Ground-glass opacity is in contrast to consolidation, in which the pulmonary vascular markings are obscured.[3][5] GGO can be used to describe both focal and diffuse areas of increased density.[5] Subtypes of GGOs include diffuse, nodular, centrilobular, mosaic, crazy paving, halo sign, and reversed halo sign.[6]

Causes

The differential diagnosis for ground-glass opacities is broad. General etiologies include infections, interstitial lung diseases, pulmonary edema, pulmonary hemorrhage, and neoplasm. A correlation of imaging with a patient's clinical features is useful in narrowing the diagnosis.[6][7] GGOs can be seen in normal lungs. Upon expiration there is less air in the lungs, leading to a relative increase in density of the tissue, and thus increased attenuation on CT. Furthermore, when a patient lays supine for a CT scan, the posterior lungs are in a dependent position, causing partial collapse of the posterior alveoli. This leads to an increase in density of the tissue, resulting increased attenuation and a possible ground-glass appearance on CT.[3]

Infectious causes

In the setting of pneumonia, the presence of GGO (as opposed to consolidation) is a useful diagnostic clue. Most bacterial infections lead to lobar consolidation, while atypical pneumonias may cause GGOs. It is important to note that while many of the pulmonary infections listed below may lead to GGOs, this does not occur in every case.[2][6][7][8][9]

 
High-Resolution CT image in a patient with Pneumocystis pneumonia infection showing ground-glass opacities.

Bacterial

Viral

Fungal

Parasitic

Non-infectious causes

 
CT image showing patchy areas of ground-glass opacities representing pulmonary edema.

Exposures

Idiopathic interstitial pneumonia

Neoplastic processes

Additional causes

Patterns

There are seven general patterns of ground-glass opacities.[6] When combined with a patient's clinical signs and symptoms, the GGO pattern seen on imaging is useful in narrowing the differential diagnosis. It is important to note that while some disease processes present as only one pattern, many can present with a mixture of GGO patterns.[6]

Diffuse

The diffuse pattern typically refers to GGOs in multiple lobes of one or both lungs. Broadly, a diffuse pattern of GGO can be caused by displacement of air with fluid, inflammatory debris, or fibrosis. Cardiogenic pulmonary edema and ARDS are common causes of a fluid-filled lung. Diffuse alveolar hemorrhage is a rarer cause of diffuse GGO seen in some types of vasculitis, autoimmune conditions, and bleeding disorders.[6]

Inflammation and fibrosis can also cause diffuse GGOs. Pneumocystis pneumonia, an infection typically seen in immunocompromised (e.g. patients with AIDS) or immunosuppressed individuals, is a classic cause of diffuse GGOs. Many viral pneumonias and idiopathic interstitial pneumonias can also lead to a diffuse GGO pattern. Radiation pneumonitis, a side effect of pulmonary radiation therapy, can lead to pulmonary fibrosis and diffuse GGOs.[6]

Nodular

There are numerous potential causes of nodular GGOs which can be broadly separated into benign and malignant conditions. Benign conditions potentially leading to the formation of nodular GGOs include aspergillosis, acute eosinophilic pneumonia, focal interstitial fibrosis, granulomatosis with polyangiitis, IgA vasculitis, organizing pneumonia, pulmonary contusion, pulmonary cryptococcus, and thoracic endometriosis. Focal interstitial fibrosis presents a unique challenge when differentiating from malignant nodular GGOs on CT imaging. It is typically persistent over long-term imaging follow-up and shares a similar appearance to malignant nodular GGOs.[9]

Pre-malignant or malignant causes of nodular GGOs include adenocarcinoma, adenocarcinoma in situ, and atypical adenomatous hyperplasia (AAH). One large review study found that 80% of nodular GGOs which were present on repeated CT imaging represented either pre-malignant or malignant growths. Differentiating between pre-malignancy and malignancy on the basis of CT alone can pose a challenge to radiologists; however, there are several features that are indicative of pre-malignant nodules. AAH is a pre-malignant cause of nodular GGO and is more commonly associated with lower attenuation on CT and smaller nodule size (<10 mm) compared to adenocarcinoma.[10] In addition, AAH often lacks the solid features and spiculated appearance that are often associated with malignant growths.[9] In contrast, as adenocarcinoma becomes invasive it will more often cause retraction of adjacent pleura and may show an increase in vascular markings. Nodules >15 mm almost always represent an invasive adenocarcinoma.[9][10]

Centrilobular

Centrilobular GGOs refer to opacities occurring within one or multiple secondary lobules of the lung, which consist of a respiratory bronchiole, small pulmonary artery, and the surrounding tissue.[3] A defining feature of these GGOs is the lack of involvement of the interlobular septum. Potential causes of centrilobular GGOs include pulmonary calcifications from metastatic disease, some types of idiopathic interstitial pneumonias, hypersensitivity pneumonitis, aspiration pneumonitis, cholesterol granulomas, and pulmonary capillary hemangiomastosis.[6]

Mosaic

A mosaic pattern of GGO refers to multiple irregular areas of both increased attenuation and decreased attenuation on CT. It is often the result of occlusion of small pulmonary arteries or obstruction of small airways leading to air trapping.[6] Sarcoidosis is an additional cause of a mosaic GGOs due to the formation of granulomas in interstitial areas. This may coexist with granulomatosis with polyangiitis, leading to diffuse areas of increased attenuation with ground-glass appearance.[6]

Crazy paving

The crazy paving pattern may occur when there is both interlobular and intralobular widening. This sometimes resembles a road paved with irregular bricks or tiles. It is typically diffuse, involving larger areas of one or multiple lobes. There are a variety of potential causes, including Pneumocystis pneumonia, late-stage adenocarcinoma, pulmonary edema, some types of idiopathic interstitial pneumonias, diffuse alveolar hemorrhage, sarcoidosis, and pulmonary alveolar proteinosis.[6] COVID-19 has also been shown to occasionally cause GGOs with a crazy paving pattern.[11]

Halo sign

A halo sign refers to a GGO that fills the area around a consolidation or nodule. This is a most commonly seen in various types of pulmonary infections, including CMV pneumonia, tuberculosis, nocardia infection, some fungal pneumonias, and septic emboli. Schistosomiasis, a parasitic infection, also commonly presents with the halo sign. Important non-infectious causes include granulomatosis with polyangiitis, metastatic disease with pulmonary hemorrhage, and some types of idiopathic interstitial pneumonias.[6]

Reversed halo sign

A reversed halo sign is a central ground-glass opacity surrounded by denser consolidation. According to published criteria, the consolidation should form more than three-fourths of a circle and be at least 2 mm thick.[12] It is often suggestive of organizing pneumonia,[13] but is only seen in about 20% of individuals with this condition.[12] It can also be present in lung infarction where the halo consists of hemorrhage,[14] as well as in infectious diseases such as paracoccidioidomycosis, tuberculosis, and aspergillosis, as well as in granulomatosis with polyangiitis, lymphomatoid granulomatosis, and sarcoidosis.[15]

  •  

    CT showing diffuse ground-glass opacities in periphery of both lungs in patient with COVID-19.

  •  

    CT image showing ground-glass nodule (circled).

  •  

    CT image showing centrilobular pattern of GGOs in patient with pulmonary tuberculosis. Note the small, nodular areas of increased attenuation in both lungs.

  •  

    CT image showing mosaic attenuation pattern in patient with hypersensitivity pneumonitis. Note the alternating, patchy areas of increased and decreased attenuation, particularly in the left lung (screen right).

  •  

    CT image showing crazy paving pattern of ground-glass opacities in both lungs.

  •  

    CT image showing halo sign in patient with pulmonary aspergillosis. Note ground-glass opacification surrounding the area of consolidation (circled).

  •  

    CT image of reversed halo sign in patient with organizing pneumonia.

COVID-19

 
CT image in patient with COVID-19 showing bilateral ground-glass opacities at the periphery of both lungs.

Ground-glass opacity is among the most common imaging findings in patients with confirmed COVID-19.[16][17] One systematic review found that among patients with COVID-19 and abnormal lung findings on CT, greater than 80% had GGOs, with greater than 50% having mixed GGOs and consolidation.[16] GGOs with mixed consolidation has most often been found in elderly populations.[18] Several studies have described a pattern among initial, intermediate, and hospital discharge imaging findings in the disease course of COVID-19. Most commonly, initial CT imaging reveals bilateral GGOs at the periphery of the lungs. During initial stages, this is most often found in the lower lobes, although involvement of the upper lobes and right middle lobe has also been reported early in the disease course.[16][18] This is in contrast to the two similar coronaviruses, SARS and MERS, which more commonly involve only one lung on initial imaging.[19][20] As the COVID-19 infection progresses, GGOs typically become more diffuse and often progress to consolidation.[11][18] This is sometimes accompanied by the development of a crazy paving pattern and interlobular septal thickening.[18] In many cases the most severe pulmonary CT abnormalities occurred within 2 weeks after symptoms began.[17] At this point, many individuals begin showing resolution of consolidation and GGOs as symptoms improve. However, some patients have worsening symptoms and imaging findings, with further increase in septal thickening, GGOs, and consolidation. These patients may develop lung "white-out" with progression to acute respiratory distress syndrome (ARDS) requiring treatment escalation.[17][21]

Preliminary reports have shown many patients have residual GGOs at time of discharge from the hospital. Due to the novelty of COVID-19, large studies investigating the long-term pulmonary CT changes have yet to be completed. However, long-term pulmonary changes have been seen in patients after recovery from SARS and MERS, suggesting the possibility of similar long-term complications in patients who have recovered from acute COVID-19 infection.[22]

History

The first usage of "ground-glass opacity" by a major radiological society occurred in a 1984 publication of the American Journal of Roentgenology. It was published as part of a glossary of recommended nomenclature from the Fleischner Society, a group of thoracic imaging radiologists.[23] The original published definition read as: "Any extended, finely granular pattern of pulmonary opacity within which normal anatomic details are partly obscured; from a fancied resemblance to etched or abraded glass."[23] It was again included in an updated glossary by the Fleischner Society in 2008 with a more detailed definition.[24]

See also

References

  1. ^ Goodman LR (2015). Felson's principles of chest roentgenology (Fifth ed.). Philadelphia, PA: Elsevier. pp. Supplement 3, e36–e80. ISBN 978-0-323-77795-7. OCLC 1134689400.
  2. ^ a b Mettler Jr FA (2019). Essentials of radiology (Fourth ed.). Philadelphia, PA: Elsevier. pp. 299–331. ISBN 978-0-323-56787-9. OCLC 1053711279.
  3. ^ a b c d Sharma A, Abbott G (2019). Thoracic imaging (Third ed.). Philadelphia, PA: Elsevier. ISBN 978-0-323-59699-2. OCLC 1022265855.
  4. ^ Herring W (2020). Learning radiology : recognizing the basics (4th ed.). Philadelphia: Elsevier. pp. 2–4. ISBN 978-0-323-56728-2. OCLC 1096282271.
  5. ^ a b Walker CM, Chung JH (2019). Müller's imaging of the chest (2nd ed.). Philadelphia, PA: Elsevier. pp. 109–137. ISBN 978-0-323-53179-5. OCLC 1051135278.
  6. ^ a b c d e f g h i j k l El-Sherief AH, Gilman MD, Healey TT, Tambouret RH, Shepard JA, Abbott GF, Wu CC (2014). "Clear vision through the haze: a practical approach to ground-glass opacity". Current Problems in Diagnostic Radiology. 43 (3): 140–58. doi:10.1067/j.cpradiol.2014.01.004. PMID 24791617.
  7. ^ a b Parekh M, Donuru A, Balasubramanya R, Kapur S (July 2020). "Review of the Chest CT Differential Diagnosis of Ground-Glass Opacities in the COVID Era". Radiology. 297 (3): E289–E302. doi:10.1148/radiol.2020202504. PMC 7350036. PMID 32633678.
  8. ^ Rossi SE, Erasmus JJ, McAdams HP, Sporn TA, Goodman PC (1 September 2000). "Pulmonary drug toxicity: radiologic and pathologic manifestations". Radiographics. 20 (5): 1245–59. doi:10.1148/radiographics.20.5.g00se081245. PMID 10992015.
  9. ^ a b c d Park CM, Goo JM, Lee HJ, Lee CH, Chun EJ, Im JG (1 March 2007). "Nodular ground-glass opacity at thin-section CT: histologic correlation and evaluation of change at follow-up". Radiographics. 27 (2): 391–408. doi:10.1148/rg.272065061. PMID 17374860.
  10. ^ a b Lee HY, Choi YL, Lee KS, Han J, Zo JI, Shim YM, Moon JW (March 2014). "Pure ground-glass opacity neoplastic lung nodules: histopathology, imaging, and management". AJR. American Journal of Roentgenology. 202 (3): W224-33. doi:10.2214/AJR.13.11819. PMID 24555618.
  11. ^ a b Ye Z, Zhang Y, Wang Y, Huang Z, Song B (August 2020). "Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review". European Radiology. 30 (8): 4381–4389. doi:10.1007/s00330-020-06801-0. PMC 7088323. PMID 32193638.
  12. ^ a b Foley R, et al. "Reversed halo sign (lungs)". Radiopaedia. Retrieved 2 January 2018.
  13. ^ Elicker BM, Webb WR (2012). Fundamentals of High-Resolution Lung CT: Common Findings, Common Patterns, Common Diseases, and Differential Diagnosis. Lippincott Williams & Wilkins. ISBN 9781469824796.
  14. ^ Wu G, Schmit B, Arteaga V, Palacio D (2017). "Medical image of the week: pulmonary infarction- the "reverse halo sign"". Southwest Journal of Pulmonary and Critical Care. 15 (4): 162–163. doi:10.13175/swjpcc124-17. ISSN 2160-6773.
  15. ^ Karthikeyan D (2013). High Resolution Computed Tomography of the Lungs: A Practical Guide. JP Medical Ltd. p. 256. ISBN 9789350904084.
  16. ^ a b c Bao C, Liu X, Zhang H, Li Y, Liu J (June 2020). "Coronavirus Disease 2019 (COVID-19) CT Findings: A Systematic Review and Meta-analysis". Journal of the American College of Radiology. 17 (6): 701–709. doi:10.1016/j.jacr.2020.03.006. PMC 7151282. PMID 32283052.
  17. ^ a b c Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A (July 2020). "Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients". AJR. American Journal of Roentgenology. 215 (1): 87–93. doi:10.2214/AJR.20.23034. PMID 32174129.
  18. ^ a b c d Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A (July 2020). "Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients". AJR. American Journal of Roentgenology. 215 (1): 87–93. doi:10.2214/AJR.20.23034. PMID 32174129.
  19. ^ Ooi GC, Daqing M (November 2003). "SARS: radiological features". Respirology. 8 Suppl (s1): S15-9. doi:10.1046/j.1440-1843.2003.00519.x. PMC 7169195. PMID 15018128.
  20. ^ Das KM, Lee EY, Langer RD, Larsson SG (June 2016). "Middle East Respiratory Syndrome Coronavirus: What Does a Radiologist Need to Know?". AJR. American Journal of Roentgenology. 206 (6): 1193–201. doi:10.2214/AJR.15.15363. PMID 26998804.
  21. ^ Carotti M, Salaffi F, Sarzi-Puttini P, Agostini A, Borgheresi A, Minorati D, et al. (July 2020). "Chest CT features of coronavirus disease 2019 (COVID-19) pneumonia: key points for radiologists". La Radiologia Medica. 125 (7): 636–646. doi:10.1007/s11547-020-01237-4. PMC 7270744. PMID 32500509.
  22. ^ George PM, Barratt SL, Condliffe R, Desai SR, Devaraj A, Forrest I, et al. (November 2020). "Respiratory follow-up of patients with COVID-19 pneumonia". Thorax. 75 (11): 1009–1016. doi:10.1136/thoraxjnl-2020-215314. PMC 7447111. PMID 32839287.
  23. ^ a b Tuddenham WJ (September 1984). "Glossary of terms for thoracic radiology: recommendations of the Nomenclature Committee of the Fleischner Society". AJR. American Journal of Roentgenology. 143 (3): 509–17. doi:10.2214/ajr.143.3.509. PMID 6380245.
  24. ^ Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J (March 2008). "Fleischner Society: glossary of terms for thoracic imaging". Radiology. 246 (3): 697–722. doi:10.1148/radiol.2462070712. PMID 18195376.

External links

  • Ground-Glass Opacity of the Lung Parenchyma: A Guide to Analysis with High-Resolution CT

January 18, 2023
ground, glass, opacity, finding, seen, chest, radiograph, computed, tomography, imaging, lungs, typically, defined, area, hazy, opacification, increased, attenuation, displacement, fluid, airway, collapse, fibrosis, neoplastic, process, when, substance, other,. Ground glass opacity GGO is a finding seen on chest x ray radiograph or computed tomography CT imaging of the lungs It is typically defined as an area of hazy opacification x ray or increased attenuation CT due to air displacement by fluid airway collapse fibrosis or a neoplastic process 1 When a substance other than air fills an area of the lung it increases that area s density On both x ray and CT this appears more grey or hazy as opposed to the normally dark appearing lungs Although it can sometimes be seen in normal lungs common pathologic causes include infections interstitial lung disease and pulmonary edema 2 3 High resolution CT image showing ground glass opacities in the periphery of both lungs in a patient with COVID 19 red arrows The adjacent normal lung tissue with lower attenuation appears as darker areas Contents 1 Definition 2 Causes 2 1 Infectious causes 2 1 1 Bacterial 2 1 2 Viral 2 1 3 Fungal 2 1 4 Parasitic 2 2 Non infectious causes 2 2 1 Exposures 2 2 2 Idiopathic interstitial pneumonia 2 2 3 Neoplastic processes 2 2 4 Additional causes 3 Patterns 3 1 Diffuse 3 2 Nodular 3 3 Centrilobular 3 4 Mosaic 3 5 Crazy paving 3 6 Halo sign 3 7 Reversed halo sign 4 COVID 19 5 History 6 See also 7 References 8 External linksDefinition EditIn both CT and chest radiographs normal lungs appear dark due to the relative lower density of air compared to the surrounding tissues When air is replaced by another substance e g fluid or fibrosis the density of the area increases causing the tissue to appear lighter or more grey 4 Ground glass opacity is most often used to describe findings in high resolution CT imaging of the thorax although it is also used when describing chest radiographs In CT the term refers to one or multiple areas of increased attenuation density without concealment of the pulmonary vasculature This appears more grey as opposed to the normally dark appearing air filled lung on CT imaging In chest radiographs the term refers to one or multiple areas in which the normally darker appearing air filled lung appears more opaque hazy or cloudy Ground glass opacity is in contrast to consolidation in which the pulmonary vascular markings are obscured 3 5 GGO can be used to describe both focal and diffuse areas of increased density 5 Subtypes of GGOs include diffuse nodular centrilobular mosaic crazy paving halo sign and reversed halo sign 6 Causes EditThe differential diagnosis for ground glass opacities is broad General etiologies include infections interstitial lung diseases pulmonary edema pulmonary hemorrhage and neoplasm A correlation of imaging with a patient s clinical features is useful in narrowing the diagnosis 6 7 GGOs can be seen in normal lungs Upon expiration there is less air in the lungs leading to a relative increase in density of the tissue and thus increased attenuation on CT Furthermore when a patient lays supine for a CT scan the posterior lungs are in a dependent position causing partial collapse of the posterior alveoli This leads to an increase in density of the tissue resulting increased attenuation and a possible ground glass appearance on CT 3 Infectious causes Edit In the setting of pneumonia the presence of GGO as opposed to consolidation is a useful diagnostic clue Most bacterial infections lead to lobar consolidation while atypical pneumonias may cause GGOs It is important to note that while many of the pulmonary infections listed below may lead to GGOs this does not occur in every case 2 6 7 8 9 High Resolution CT image in a patient with Pneumocystis pneumonia infection showing ground glass opacities Bacterial Edit Diffuse Mycoplasma pneumoniae Chlamydophila pneumoniae Legionella pneumophilia Focal or nodular Mycobacterium Nocardia Septic emboliViral Edit Adenovirus Coronavirus including MERS CoV SARS CoV and SARS CoV 2 Cytomegalovirus CMV Herpes Simplex Virus HSV Human metapneumovirus HMPV Influenza CT image showing ground glass opacification in the posterior of the right lung screen left Measles Respiratory Syncytial Virus RSV Varicella zosterFungal Edit Pneumocystis jirovecii PCP Invasive aspergillosis Candidiasis Mucormycosis Pulmonary cryptococcus ParacoccidioidomycosisParasitic Edit Pulmonary SchistosomiasisNon infectious causes Edit CT image showing patchy areas of ground glass opacities representing pulmonary edema Exposures Edit Aspiration pneumonitis Drug toxicity most common include cyclophosphamide amiodarone carmustine methotrexate and bleomycin Hypersensitivity pneumonitis EVALI Radiation pneumonitisIdiopathic interstitial pneumonia Edit Acute interstitial pneumonitis Desquamative interstitial pneumonia Lymphocytic interstitial pneumonia Non specific interstitial pneumonia Cryptogenic organizing pneumoniaNeoplastic processes Edit CT image showing diffuse GGOs throughout both lungs An abscess is also noted in the right lung screen left Lung adenocarcinoma Adenocarcinoma in situ of the lung Atypical adenomatous hyperplasiaAdditional causes Edit Acute eosinophilic pneumonia Cholesterol granulomas Focal interstitial fibrosis Granulomatosis with polyangiitis Lymphatoid granulomatosis Pulmonary alveolar proteinosis Pulmonary calcifications Pulmonary capillary hemangiomatosis Pulmonary contusion Pulmonary edema Pulmonary hemorrhage Pulmonary infarction Sarcoidosis Thoracic endometriosisPatterns EditThere are seven general patterns of ground glass opacities 6 When combined with a patient s clinical signs and symptoms the GGO pattern seen on imaging is useful in narrowing the differential diagnosis It is important to note that while some disease processes present as only one pattern many can present with a mixture of GGO patterns 6 Diffuse Edit The diffuse pattern typically refers to GGOs in multiple lobes of one or both lungs Broadly a diffuse pattern of GGO can be caused by displacement of air with fluid inflammatory debris or fibrosis Cardiogenic pulmonary edema and ARDS are common causes of a fluid filled lung Diffuse alveolar hemorrhage is a rarer cause of diffuse GGO seen in some types of vasculitis autoimmune conditions and bleeding disorders 6 Inflammation and fibrosis can also cause diffuse GGOs Pneumocystis pneumonia an infection typically seen in immunocompromised e g patients with AIDS or immunosuppressed individuals is a classic cause of diffuse GGOs Many viral pneumonias and idiopathic interstitial pneumonias can also lead to a diffuse GGO pattern Radiation pneumonitis a side effect of pulmonary radiation therapy can lead to pulmonary fibrosis and diffuse GGOs 6 Nodular Edit There are numerous potential causes of nodular GGOs which can be broadly separated into benign and malignant conditions Benign conditions potentially leading to the formation of nodular GGOs include aspergillosis acute eosinophilic pneumonia focal interstitial fibrosis granulomatosis with polyangiitis IgA vasculitis organizing pneumonia pulmonary contusion pulmonary cryptococcus and thoracic endometriosis Focal interstitial fibrosis presents a unique challenge when differentiating from malignant nodular GGOs on CT imaging It is typically persistent over long term imaging follow up and shares a similar appearance to malignant nodular GGOs 9 Pre malignant or malignant causes of nodular GGOs include adenocarcinoma adenocarcinoma in situ and atypical adenomatous hyperplasia AAH One large review study found that 80 of nodular GGOs which were present on repeated CT imaging represented either pre malignant or malignant growths Differentiating between pre malignancy and malignancy on the basis of CT alone can pose a challenge to radiologists however there are several features that are indicative of pre malignant nodules AAH is a pre malignant cause of nodular GGO and is more commonly associated with lower attenuation on CT and smaller nodule size lt 10 mm compared to adenocarcinoma 10 In addition AAH often lacks the solid features and spiculated appearance that are often associated with malignant growths 9 In contrast as adenocarcinoma becomes invasive it will more often cause retraction of adjacent pleura and may show an increase in vascular markings Nodules gt 15 mm almost always represent an invasive adenocarcinoma 9 10 Centrilobular Edit Centrilobular GGOs refer to opacities occurring within one or multiple secondary lobules of the lung which consist of a respiratory bronchiole small pulmonary artery and the surrounding tissue 3 A defining feature of these GGOs is the lack of involvement of the interlobular septum Potential causes of centrilobular GGOs include pulmonary calcifications from metastatic disease some types of idiopathic interstitial pneumonias hypersensitivity pneumonitis aspiration pneumonitis cholesterol granulomas and pulmonary capillary hemangiomastosis 6 Mosaic Edit A mosaic pattern of GGO refers to multiple irregular areas of both increased attenuation and decreased attenuation on CT It is often the result of occlusion of small pulmonary arteries or obstruction of small airways leading to air trapping 6 Sarcoidosis is an additional cause of a mosaic GGOs due to the formation of granulomas in interstitial areas This may coexist with granulomatosis with polyangiitis leading to diffuse areas of increased attenuation with ground glass appearance 6 Crazy paving Edit The crazy paving pattern may occur when there is both interlobular and intralobular widening This sometimes resembles a road paved with irregular bricks or tiles It is typically diffuse involving larger areas of one or multiple lobes There are a variety of potential causes including Pneumocystis pneumonia late stage adenocarcinoma pulmonary edema some types of idiopathic interstitial pneumonias diffuse alveolar hemorrhage sarcoidosis and pulmonary alveolar proteinosis 6 COVID 19 has also been shown to occasionally cause GGOs with a crazy paving pattern 11 Halo sign Edit A halo sign refers to a GGO that fills the area around a consolidation or nodule This is a most commonly seen in various types of pulmonary infections including CMV pneumonia tuberculosis nocardia infection some fungal pneumonias and septic emboli Schistosomiasis a parasitic infection also commonly presents with the halo sign Important non infectious causes include granulomatosis with polyangiitis metastatic disease with pulmonary hemorrhage and some types of idiopathic interstitial pneumonias 6 Reversed halo sign EditA reversed halo sign is a central ground glass opacity surrounded by denser consolidation According to published criteria the consolidation should form more than three fourths of a circle and be at least 2 mm thick 12 It is often suggestive of organizing pneumonia 13 but is only seen in about 20 of individuals with this condition 12 It can also be present in lung infarction where the halo consists of hemorrhage 14 as well as in infectious diseases such as paracoccidioidomycosis tuberculosis and aspergillosis as well as in granulomatosis with polyangiitis lymphomatoid granulomatosis and sarcoidosis 15 CT showing diffuse ground glass opacities in periphery of both lungs in patient with COVID 19 CT image showing ground glass nodule circled CT image showing centrilobular pattern of GGOs in patient with pulmonary tuberculosis Note the small nodular areas of increased attenuation in both lungs CT image showing mosaic attenuation pattern in patient with hypersensitivity pneumonitis Note the alternating patchy areas of increased and decreased attenuation particularly in the left lung screen right CT image showing crazy paving pattern of ground glass opacities in both lungs CT image showing halo sign in patient with pulmonary aspergillosis Note ground glass opacification surrounding the area of consolidation circled CT image of reversed halo sign in patient with organizing pneumonia COVID 19 Edit CT image in patient with COVID 19 showing bilateral ground glass opacities at the periphery of both lungs Ground glass opacity is among the most common imaging findings in patients with confirmed COVID 19 16 17 One systematic review found that among patients with COVID 19 and abnormal lung findings on CT greater than 80 had GGOs with greater than 50 having mixed GGOs and consolidation 16 GGOs with mixed consolidation has most often been found in elderly populations 18 Several studies have described a pattern among initial intermediate and hospital discharge imaging findings in the disease course of COVID 19 Most commonly initial CT imaging reveals bilateral GGOs at the periphery of the lungs During initial stages this is most often found in the lower lobes although involvement of the upper lobes and right middle lobe has also been reported early in the disease course 16 18 This is in contrast to the two similar coronaviruses SARS and MERS which more commonly involve only one lung on initial imaging 19 20 As the COVID 19 infection progresses GGOs typically become more diffuse and often progress to consolidation 11 18 This is sometimes accompanied by the development of a crazy paving pattern and interlobular septal thickening 18 In many cases the most severe pulmonary CT abnormalities occurred within 2 weeks after symptoms began 17 At this point many individuals begin showing resolution of consolidation and GGOs as symptoms improve However some patients have worsening symptoms and imaging findings with further increase in septal thickening GGOs and consolidation These patients may develop lung white out with progression to acute respiratory distress syndrome ARDS requiring treatment escalation 17 21 Preliminary reports have shown many patients have residual GGOs at time of discharge from the hospital Due to the novelty of COVID 19 large studies investigating the long term pulmonary CT changes have yet to be completed However long term pulmonary changes have been seen in patients after recovery from SARS and MERS suggesting the possibility of similar long term complications in patients who have recovered from acute COVID 19 infection 22 History EditThe first usage of ground glass opacity by a major radiological society occurred in a 1984 publication of the American Journal of Roentgenology It was published as part of a glossary of recommended nomenclature from the Fleischner Society a group of thoracic imaging radiologists 23 The original published definition read as Any extended finely granular pattern of pulmonary opacity within which normal anatomic details are partly obscured from a fancied resemblance to etched or abraded glass 23 It was again included in an updated glossary by the Fleischner Society in 2008 with a more detailed definition 24 See also EditPulmonary consolidation Pulmonary infiltrateReferences Edit Goodman LR 2015 Felson s principles of chest roentgenology Fifth ed Philadelphia PA Elsevier pp Supplement 3 e36 e80 ISBN 978 0 323 77795 7 OCLC 1134689400 a b Mettler Jr FA 2019 Essentials of radiology Fourth ed Philadelphia PA Elsevier pp 299 331 ISBN 978 0 323 56787 9 OCLC 1053711279 a b c d Sharma A Abbott G 2019 Thoracic imaging Third ed Philadelphia PA Elsevier ISBN 978 0 323 59699 2 OCLC 1022265855 Herring W 2020 Learning radiology recognizing the basics 4th ed Philadelphia Elsevier pp 2 4 ISBN 978 0 323 56728 2 OCLC 1096282271 a b Walker CM Chung JH 2019 Muller s imaging of the chest 2nd ed Philadelphia PA Elsevier pp 109 137 ISBN 978 0 323 53179 5 OCLC 1051135278 a b c d e f g h i j k l El Sherief AH Gilman MD Healey TT Tambouret RH Shepard JA Abbott GF Wu CC 2014 Clear vision through the haze a practical approach to ground glass opacity Current Problems in Diagnostic Radiology 43 3 140 58 doi 10 1067 j cpradiol 2014 01 004 PMID 24791617 a b Parekh M Donuru A Balasubramanya R Kapur S July 2020 Review of the Chest CT Differential Diagnosis of Ground Glass Opacities in the COVID Era Radiology 297 3 E289 E302 doi 10 1148 radiol 2020202504 PMC 7350036 PMID 32633678 Rossi SE Erasmus JJ McAdams HP Sporn TA Goodman PC 1 September 2000 Pulmonary drug toxicity radiologic and pathologic manifestations Radiographics 20 5 1245 59 doi 10 1148 radiographics 20 5 g00se081245 PMID 10992015 a b c d Park CM Goo JM Lee HJ Lee CH Chun EJ Im JG 1 March 2007 Nodular ground glass opacity at thin section CT histologic correlation and evaluation of change at follow up Radiographics 27 2 391 408 doi 10 1148 rg 272065061 PMID 17374860 a b Lee HY Choi YL Lee KS Han J Zo JI Shim YM Moon JW March 2014 Pure ground glass opacity neoplastic lung nodules histopathology imaging and management AJR American Journal of Roentgenology 202 3 W224 33 doi 10 2214 AJR 13 11819 PMID 24555618 a b Ye Z Zhang Y Wang Y Huang Z Song B August 2020 Chest CT manifestations of new coronavirus disease 2019 COVID 19 a pictorial review European Radiology 30 8 4381 4389 doi 10 1007 s00330 020 06801 0 PMC 7088323 PMID 32193638 a b Foley R et al Reversed halo sign lungs Radiopaedia Retrieved 2 January 2018 Elicker BM Webb WR 2012 Fundamentals of High Resolution Lung CT Common Findings Common Patterns Common Diseases and Differential Diagnosis Lippincott Williams amp Wilkins ISBN 9781469824796 Wu G Schmit B Arteaga V Palacio D 2017 Medical image of the week pulmonary infarction the reverse halo sign Southwest Journal of Pulmonary and Critical Care 15 4 162 163 doi 10 13175 swjpcc124 17 ISSN 2160 6773 Karthikeyan D 2013 High Resolution Computed Tomography of the Lungs A Practical Guide JP Medical Ltd p 256 ISBN 9789350904084 a b c Bao C Liu X Zhang H Li Y Liu J June 2020 Coronavirus Disease 2019 COVID 19 CT Findings A Systematic Review and Meta analysis Journal of the American College of Radiology 17 6 701 709 doi 10 1016 j jacr 2020 03 006 PMC 7151282 PMID 32283052 a b c Salehi S Abedi A Balakrishnan S Gholamrezanezhad A July 2020 Coronavirus Disease 2019 COVID 19 A Systematic Review of Imaging Findings in 919 Patients AJR American Journal of Roentgenology 215 1 87 93 doi 10 2214 AJR 20 23034 PMID 32174129 a b c d Salehi S Abedi A Balakrishnan S Gholamrezanezhad A July 2020 Coronavirus Disease 2019 COVID 19 A Systematic Review of Imaging Findings in 919 Patients AJR American Journal of Roentgenology 215 1 87 93 doi 10 2214 AJR 20 23034 PMID 32174129 Ooi GC Daqing M November 2003 SARS radiological features Respirology 8 Suppl s1 S15 9 doi 10 1046 j 1440 1843 2003 00519 x PMC 7169195 PMID 15018128 Das KM Lee EY Langer RD Larsson SG June 2016 Middle East Respiratory Syndrome Coronavirus What Does a Radiologist Need to Know AJR American Journal of Roentgenology 206 6 1193 201 doi 10 2214 AJR 15 15363 PMID 26998804 Carotti M Salaffi F Sarzi Puttini P Agostini A Borgheresi A Minorati D et al July 2020 Chest CT features of coronavirus disease 2019 COVID 19 pneumonia key points for radiologists La Radiologia Medica 125 7 636 646 doi 10 1007 s11547 020 01237 4 PMC 7270744 PMID 32500509 George PM Barratt SL Condliffe R Desai SR Devaraj A Forrest I et al November 2020 Respiratory follow up of patients with COVID 19 pneumonia Thorax 75 11 1009 1016 doi 10 1136 thoraxjnl 2020 215314 PMC 7447111 PMID 32839287 a b Tuddenham WJ September 1984 Glossary of terms for thoracic radiology recommendations of the Nomenclature Committee of the Fleischner Society AJR American Journal of Roentgenology 143 3 509 17 doi 10 2214 ajr 143 3 509 PMID 6380245 Hansell DM Bankier AA MacMahon H McLoud TC Muller NL Remy J March 2008 Fleischner Society glossary of terms for thoracic imaging Radiology 246 3 697 722 doi 10 1148 radiol 2462070712 PMID 18195376 External links EditGround Glass Opacity of the Lung Parenchyma A Guide to Analysis with High Resolution CT Retrieved from https en wikipedia org w index php title Ground glass opacity amp oldid 1124845177, wikipedia, wiki, book, books, library,

article

, read, download, free, free download, mp3, video, mp4, 3gp, jpg, jpeg, gif, png, picture, music, song, movie, book, game, games.